Generic Name and Formulations:
Crofelemer 125mg; delayed-release tablets; enteric-coated.
Company:
Napo Pharmaceuticals, Inc.

Select therapeutic use: Diarrhea
Indications for MYTESI:
Symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy.

Adult:
Swallow whole. One tab twice daily.

Children:
<18yrs: not established.

Warnings/Precautions:
Rule out infectious etiologies of diarrhea before starting. Pregnancy (Cat. C). Nursing mothers: not recommended.

Pharmacological Class:
Antidiarrheal.

Adverse Reactions:
Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin.

Note:
Formerly known under the brand name Fulyzaq.

Generic Availability:
NO

How Supplied:
Tabs—60